Clinical trial
Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
NCT02270242 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- July 10, 2019
- Enrollment
- 9,006 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, interventional cardiology